Risk scores' performance and their impact on operative decision-making in left-sided endocarditis: a cohort study.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 30 06 2022
accepted: 20 10 2022
pubmed: 9 11 2022
medline: 10 1 2023
entrez: 8 11 2022
Statut: ppublish

Résumé

The accuracy of contemporary risk scores in predicting perioperative mortality in infective endocarditis (IE) remains controversial. The aim is to evaluate the performance of existent mortality risk scores for cardiovascular surgery in IE and the impact on operability at high-risk thresholds. A single-center retrospective review of adult patients diagnosed with acute left-sided IE undergoing surgery from May 2014 to August 2019 (n = 142) was done. Individualized risk calculation was obtained according to the available mortality risk scores: EuroScore I and II, PALSUSE, Risk-E, Costa, De Feo-Cotrufo, AEPEI, STS-risk, STS-IE, APORTEI, and ICE-PCS scores. A cross-validation analysis was performed on the score with the best area under the curve (AUC). The 30-day survival was 96.5% (95%CI 91-98%). The score with worse area under the curve (AUC = 0.6) was the STS-IE score, while the higher was for the RISK-E score (AUC = 0.89). The AUC of the majority of risk scores suggested acceptable performance; however, statistically significant differences in expected versus observed mortalities were common. The cross-validation analysis showed that a large number of survivors (> 75%) would not have been operated if arbitrary high-risk threshold estimates had been used to deny surgery. The observed mortality in our cohort is significantly lower than is predicted by contemporary risk scores. Despite the reasonable numeric performance of the analyzed scores, their utility in judging the operability of a given patient remains questionable, as demonstrated in the cross-validation analysis. Future guidelines may advise that denial of surgery should only follow a highly experienced Endocarditis Team evaluation.

Identifiants

pubmed: 36346471
doi: 10.1007/s10096-022-04516-2
pii: 10.1007/s10096-022-04516-2
pmc: PMC9816251
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

33-42

Informations de copyright

© 2022. The Author(s).

Références

Thorac Cardiovasc Surg. 2018 Jun;66(4):333-335
pubmed: 28427095
Heart Vessels. 2015 Mar;30(2):227-34
pubmed: 24463846
Ann Thorac Surg. 2018 May;105(5):1419-1428
pubmed: 29577924
Rev Esp Cardiol (Engl Ed). 2015 May;68(5):363-8
pubmed: 25659510
Int J Cardiol. 2018 Oct 1;268:99
pubmed: 29934231
Eur Heart J. 2015 Nov 21;36(44):3075-3128
pubmed: 26320109
Ann Thorac Surg. 2008 Apr;85(4):1490-5
pubmed: 18355567
Heart. 2017 Sep;103(18):1435-1442
pubmed: 28432158
Eur J Cardiothorac Surg. 2012 Apr;41(4):734-44; discussion 744-5
pubmed: 22378855
Scand Cardiovasc J. 2019 Jun;53(3):117-124
pubmed: 31007096
Eur J Cardiothorac Surg. 2020 Apr 1;57(4):724-731
pubmed: 31782783
Ann Thorac Surg. 2018 May;105(5):1411-1418
pubmed: 29577925
Hellenic J Cardiol. 2020 Jul - Aug;61(4):246-252
pubmed: 30690140
J Am Coll Cardiol. 2017 Dec 5;70(22):2795-2804
pubmed: 29191329
Eur J Cardiothorac Surg. 2018 May 1;53(5):1049-1054
pubmed: 29228242
ScientificWorldJournal. 2012;2012:307571
pubmed: 22536134
J Card Surg. 2020 Nov;35(11):3034-3040
pubmed: 32827161
Circulation. 2015 Jan 13;131(2):131-40
pubmed: 25480814
Arch Intern Med. 2009 Jul 27;169(14):1290-8
pubmed: 19636030
Med Clin (Barc). 2003 Apr 26;120(15):568-73
pubmed: 12729524
Clin Infect Dis. 2000 Apr;30(4):633-8
pubmed: 10770721
Arch Intern Med. 2009 Mar 9;169(5):463-73
pubmed: 19273776
Eur Heart J. 2019 Oct 14;40(39):3222-3232
pubmed: 31504413
Ann Thorac Surg. 2019 Oct;108(4):1101-1106
pubmed: 31276645
Infection. 2019 Dec;47(6):879-895
pubmed: 31254171
Medicine (Baltimore). 2015 Oct;94(43):e1816
pubmed: 26512582
Int J Cardiol. 2014 Jul 15;175(1):133-7
pubmed: 24852838
Rev Bras Cir Cardiovasc. 2007 Apr-Jun;22(2):192-200
pubmed: 17992324
J Thorac Cardiovasc Surg. 2011 Jan;141(1):98-106.e1-2
pubmed: 21168017
J Am Heart Assoc. 2017 Jul 20;6(7):
pubmed: 28729412
Clin Microbiol Infect. 2021 Oct;27(10):1422-1430
pubmed: 34620380
Eur Heart J. 2019 Oct 14;40(39):3233-3236
pubmed: 31589743
Eur J Cardiothorac Surg. 1999 Jul;16(1):9-13
pubmed: 10456395
Heart. 2016 Jun 15;102(12):950-7
pubmed: 26869640
Med Sci Monit. 2017 Jul 25;23:3617-3626
pubmed: 28740070
J Am Heart Assoc. 2016 Apr 18;5(4):e003016
pubmed: 27091179
Int J Cardiol. 2017 Aug 15;241:97-102
pubmed: 28390740
Eur J Cardiothorac Surg. 2016 Mar;49(3):944-51
pubmed: 26116921

Auteurs

A Fernández-Cisneros (A)

Cardiovascular Surgery Department, Hospital Clínic - IDIBAPS, University of Barcelona, C/Villarroel 170, 08036, Barcelona, CP, Spain.

M Hernández-Meneses (M)

Infectious Diseases Service, Hospital Clínic - IDIBAPS, University of Barcelona, Barcelona, Spain.

J Llopis (J)

Department of Genetics, Microbiology and Statistics, University of Barcelona, Barcelona, Spain.

E Sandoval (E)

Cardiovascular Surgery Department, Hospital Clínic - IDIBAPS, University of Barcelona, C/Villarroel 170, 08036, Barcelona, CP, Spain.
Departament de Cirurgia i Especialitats Medicoquirúrgiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.

D Pereda (D)

Cardiovascular Surgery Department, Hospital Clínic - IDIBAPS, University of Barcelona, C/Villarroel 170, 08036, Barcelona, CP, Spain.
Departament de Cirurgia i Especialitats Medicoquirúrgiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.

J Alcocer (J)

Cardiovascular Surgery Department, Hospital Clínic - IDIBAPS, University of Barcelona, C/Villarroel 170, 08036, Barcelona, CP, Spain.

C Barriuso (C)

Cardiovascular Surgery Department, Hospital Clínic - IDIBAPS, University of Barcelona, C/Villarroel 170, 08036, Barcelona, CP, Spain.

M Castellá (M)

Cardiovascular Surgery Department, Hospital Clínic - IDIBAPS, University of Barcelona, C/Villarroel 170, 08036, Barcelona, CP, Spain.
Departament de Cirurgia i Especialitats Medicoquirúrgiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.

J Ambrosioni (J)

Infectious Diseases Service, Hospital Clínic - IDIBAPS, University of Barcelona, Barcelona, Spain.

J M Pericàs (JM)

Infectious Diseases Service, Hospital Clínic - IDIBAPS, University of Barcelona, Barcelona, Spain.
Liver Unit, Internal Medicine Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Research, CIBERehd, Barcelona, Spain.

B Vidal (B)

Cardiology Department, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.

C Falces (C)

Cardiology Department, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.

C Ibáñez (C)

Anesthesiology Department, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.

J Perdomo (J)

Anesthesiology Department, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.

I Rovira (I)

Departament de Cirurgia i Especialitats Medicoquirúrgiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
Anesthesiology Department, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.

C García-de-la-María (C)

Infectious Diseases Service, Hospital Clínic - IDIBAPS, University of Barcelona, Barcelona, Spain.

A Moreno (A)

Infectious Diseases Service, Hospital Clínic - IDIBAPS, University of Barcelona, Barcelona, Spain.

M Almela (M)

Microbiology Department, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.

A Perisinotti (A)

Nuclear Medicine Department, Biomaterials and Nanomedicine (CIBER-BBN), Hospital Clinic-IDIBAPS, University of Barcelona & Biomedical Research Networking Center of Bioengineering, Barcelona, Spain.

A Dahl (A)

Infectious Diseases Service, Hospital Clínic - IDIBAPS, University of Barcelona, Barcelona, Spain.

P Castro (P)

Internal Medicine Department, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.

J M Miró (JM)

Infectious Diseases Service, Hospital Clínic - IDIBAPS, University of Barcelona, Barcelona, Spain. jmmiro@ub.edu.

E Quintana (E)

Cardiovascular Surgery Department, Hospital Clínic - IDIBAPS, University of Barcelona, C/Villarroel 170, 08036, Barcelona, CP, Spain. eduquintana@ub.edu.
Departament de Cirurgia i Especialitats Medicoquirúrgiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain. eduquintana@ub.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH